Cucurbitacin e inhibits breast tumor metastasis by suppressing cell migration and invasion

Breast Cancer Research and Treatment

Volumn 135, Issue 2, 2012, Pages 445-458

  Zhang, Tao ^a   Li, Jingjie ^a   Dong, Yanmin ^a   Zhai, Dong ^a   Lai, Li ^a   Dai, Fujun ^a   Deng, Huayun ^a   Chen, Yihua ^a   Liu, Mingyao ^a,b   Yi, Zhengfang ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Breast cancer; Cucurbitacin E; Invasion; Metastasis; Migration

Indexed keywords

ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 3; CASPASE 3; CUCURBITACIN; CUCURBITACIN E; CYCLINE; FOCAL ADHESION KINASE; MATRIX METALLOPROTEINASE; PROTEIN TYROSINE KINASE; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST METASTASIS; BREAST TUMOR; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WEIGHT CHANGE; WEIGHT REDUCTION; WESTERN BLOTTING; ZYMOGRAPHY;

ACTINS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; TRITERPENES; TUMOR BURDEN;

EID: 84866528843     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2175-5     Document Type: Article

References (51)

1. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4): 212-236. doi:10.3322/caac.20121
2. Weigelt B, Peterse JL, van't Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5(8):591-602. doi:10.1038/nrc1670 (Pubitemid 41081385)
3. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9(4):274-284. doi:10.1038/nrc2622
4. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12(8):895-904. doi:10.1038/nm1469 (Pubitemid 44175140)
5. Ideses Y, Brill-Karniely Y, Haviv L, Ben-Shaul A, Bernheim-Groswasser A (2008) Arp2/3 branched actin network mediates filopodia-like bundles formation in vitro. PLoS ONE 3(9):e3297. doi:10.1371/journal.pone.0003297
6. Li Z, Kim ES, Bearer EL (2002) Arp2/3 complex is required for actin polymerization during platelet shape change. Blood 99(12): 4466-4474 (Pubitemid 34627216)
7. Yamakita Y, Oosawa F, Yamashiro S, Matsumura F (2003) Caldesmon inhibits Arp2/3-mediated actin nucleation. J Biol Chem 278(20):17937-17944. doi:10.1074/jbc.M208739200M208739200 (Pubitemid 36799400)
8. Gabarra-Niecko V, Schaller MD, Dunty JM (2003) FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 22(4):359-374 (Pubitemid 36791892)
9. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1): 52-67. doi:10.1016/j.cell.2010.03.015
10. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269(2):199-225. doi:10.1016/j.canlet.2008. 03.009
11. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6(1):56-68. doi:10.1038/nrm1549 (Pubitemid 40064899)
12. Siesser PM, Hanks SK (2006) The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 12(11 Pt 1):3233-3237. doi:10.1158/1078-0432.CCR-06-0456
13. Chambliss OL, Jones CM (1966) Cucurbitacins: specific insect attractants in Cucurbitaceae. Science 153(3742):1392-1393. doi: 10.1126/science.153.3742. 1392
14. Kocyan A, Zhang LB, Schaefer H, Renner SS (2007) A multilocus chloroplast phylogeny for the Cucurbitaceae and its implications for character evolution and classification. Mol Phylogenet Evol 44(2):553-577. doi:10.1016/j.ympev.2006. 12.022 (Pubitemid 47048928)
15. Duncan KL, Duncan MD, Alley MC, Sausville EA (1996) Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells. Biochem Pharmacol 52(10): 1553-1560 (Pubitemid 26375461)
16. Momma K, Masuzawa Y, Nakai N, Chujo M, Murakami A, Kioka N, Kiyama Y, Akita T, Nagao M (2008) Direct interaction of Cucurbitacin E isolated from Alsomitra macrocarpa to actin filament. Cytotechnology 56(1):33-39. doi:10.1007/s10616-007-9100-5
17. Greige-Gerges H, Abou Khalil R, Chahine R, Haddad C, Harb W, Ouaini N (2007) Effect of cucurbitacins on bilirubin-albumin binding in human plasma. Life Sci 80(6):579-585. doi:10.1016/ j.lfs.2006.10.005 (Pubitemid 46043484)
18. Musza LL, Speight P, McElhiney S, Barrow CJ, Gillum AM, Cooper R, Killar LM (1994) Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides. J Nat Prod 57(11):1498-1502
19. Dong Y, Lu B, Zhang X, Zhang J, Lai L, Li D,WuY, Song Y, Luo J, Pang X, Yi Z, LiuM(2010) Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. Carcinogenesis 31(12):2097-2104. doi:10.1093/carcin/bgq167
20. Shan D, Chen L, Njardarson JT, Gaul C, Ma X, Danishefsky SJ, Huang XY (2005) Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc Natl Acad Sci USA 102(10):3772-3776. doi:10.1073/pnas.0500658102 (Pubitemid 40354687)
21. Chen L, Yang S, Jakoncic J, Zhang JJ, Huang XY (2010) Migrastatin analogues target fascin to block tumour metastasis. Nature 464(7291):1062-1066. doi:10.1038/nature08978
22. Pan X, Han H, Wang L, Yang L, Li R, Li Z, Liu J, Zhao Q, Qian M, Liu M, Du B (2011) Nitidine chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway. Cancer Lett 313(2):181-191. doi:10.1016/ j.canlet.2011.09.001
23. Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST (2008) Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis 29(11):2096-2105. doi:10.1093/carcin/bgn203
24. Gaul C, Njardarson JT, Shan D, Dorn DC, Wu KD, Tong WP, Huang XY, Moore MA, Danishefsky SJ (2004) The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. J Am Chem Soc 126(36):11326-11337. doi:10.1021/ ja048779q (Pubitemid 39223205)
25. Yi ZF, Cho SG, Zhao H,WuYY, Luo J, Li D, Yi T, Xu X,WuZ, Liu M (2009) A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells. Int J Cancer 124(4):843-852. doi:10.1002/ijc.24027
26. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, Spencer KS, Cheresh DA, Schlaepfer DD (2003) Differential regulation of cell motility and invasion by FAK. J Cell Biol 160(5):753-767. doi:10.1083/jcb.20021 2114jcb.200212114 (Pubitemid 36298270)
27. To C, Shilton BH, Di Guglielmo GM (2010) Synthetic triterpenoids target the Arp2/3 complex and inhibit branched actin polymerization. J Biol Chem 285(36):27944-27957. doi:10.1074/ jbc.M110.103036
28. Serrels B, Serrels A, Brunton VG, Holt M, McLean GW, Gray CH, Jones GE, Frame MC (2007) Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex. Nat Cell Biol 9(9):1046-1056. doi:10.1038/ncb1626 (Pubitemid 47338144)
29. Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D, Fujise K, Liu M (2009) Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res 69(2):518-525. doi: 10.1158/0008-5472.CAN-08-2531
30. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52(6): 1399-1405
31. Pulaski BA, Ostrand-Rosenberg S (1998) Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res 58(7): 1486-1493 (Pubitemid 28193612)
32. Malkas LH, Herbert BS, Abdel-Aziz W, Dobrolecki LE, Liu Y, Agarwal B, Hoelz D, Badve S, Schnaper L, Arnold RJ, Mechref Y, Novotny MV, Loehrer P, Goulet RJ, Hickey RJ (2006) A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci USA 103(51):19472-19477. doi:10.1073/pnas.0604614103 (Pubitemid 46026055)
33. Blanc C, Deveraux QL, Krajewski S, Janicke RU, Porter AG, Reed JC, Jaggi R, Marti A (2000) Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res 60(16):4386-4390 (Pubitemid 32103616)
34. Diez S, Gerisch G, Anderson K, Muller-Taubenberger A, Bretschneider T (2005) Subsecond reorganization of the actin network in cell motility and chemotaxis. Proc Natl Acad Sci USA 102(21):7601-7606. doi:10.1073/pnas. 0408546102 (Pubitemid 40741017)
35. Otto AM, Muller CS, Huff T, Hannappel E (2002) Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells. J Cancer Res Clin Oncol 128(5):247-256. doi:10.1007/s00432-002-0332-7 (Pubitemid 34591582)
36. Machesky LM, Insall RH (1998) Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr Biol 8(25):1347-1356 (Pubitemid 29020143)
37. Robinson RC, Turbedsky K, Kaiser DA, Marchand JB, Higgs HN, Choe S, Pollard TD (2001) Crystal structure of Arp2/3 complex. Science 294(5547):1679-1684. doi:10.1126/science.1066333 294/5547/1679 (Pubitemid 33104831)
38. Kelleher JF, Atkinson SJ, Pollard TD (1995) Sequences, structural models, and cellular localization of the actin-related proteins Arp2 and Arp3 from Acanthamoeba. J Cell Biol 131(2):385-397
39. Wu X, Gan B, Yoo Y, Guan JL (2005) FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. Dev Cell 9(2):185-196. doi:10.1016/j.devcel.2005.06.006 (Pubitemid 41051738)
40. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92(8):827-839. doi:10.1161/01.RES.000007 0112.80711.3D92/8/827 (Pubitemid 36542523)
41. Ogier C, Bernard A, Chollet AM, Le Diguardher T, Hanessian S, Charton G, Khrestchatisky M, Rivera S (2006) Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 54(4):272-284. doi:10.1002/glia.20349 (Pubitemid 44316232)
42. Sadzuka Y, Hatakeyama H, Daimon T, Sonobe T (2008) Screening of biochemical modulator by tumor cell permeability of doxorubicin. Int J Pharm 354(1-2):63-69. doi:10.1016/j.ijpharm. 2007.10.015 (Pubitemid 351400329)
43. Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3(5):362-374. doi:10.1038/nrc1075nrc1075 (Pubitemid 37328856)
44. Sun C, Zhang M, Shan X, Zhou X, Yang J, Wang Y, Li-Ling J, Deng Y (2010) Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling. J Cancer Res Clin Oncol 136(4):603-610. doi:10.1007/s00432-009-0698-x
45. Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116(2):167-179 (Pubitemid 38167310)
46. Sein TT, Thant AA, Hiraiwa Y, Amin AR, Sohara Y, Liu Y, Matsuda S, Yamamoto T, Hamaguchi M (2000) A role for FAK in the Concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9. Oncogene 19(48):5539-5542. doi:10.1038/ sj.onc.1203932 (Pubitemid 32000922)
47. Chen JS, Huang XH, Wang Q, Chen XL, Fu XH, Tan HX, Zhang LJ, Li W, Bi J (2010) FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 27(2):71-82. doi:10.1007/s10585-010-9306-3
48. Lu J, Guo H, Treekitkarnmongkol W, Li P, Zhang J, Shi B, Ling C, Zhou X, Chen T, Chiao PJ, Feng X, Seewaldt VL, Muller WJ, Sahin A, Hung MC, Yu D (2009) 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell 16(3):195-207. doi:10.1016/j.ccr.2009.08.010
49. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284(5751):67-68 (Pubitemid 10098769)
50. Curran S, Murray GI (1999) Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189(3):300-308. doi:10.1002/ (SICI)1096-9896(199911) 189:3\300:AID-PATH456[3.0.CO;2-C (Pubitemid 29489213)
51. Karavasilis V, Malamou-Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalofonos H, Fountzilas G, Fotsis T, Pavlidis N (2005) Matrix metalloproteinases in carcinoma of unknown primary. Cancer 104(10):2282-2287. doi:10.1002/cncr. 21454 (Pubitemid 41579976)